OncoMed Pharmaceuticals Inc Deferred Revenue (Non-Current)
OncoMed Pharmaceuticals Inc had Deferred Revenue (Non-Current) of $9.75 million as of 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent › Deferred Revenue, Noncurrent
us-gaap:DeferredRevenueNoncurrent · last filed 2018-05-08
- 2018-03-31: Deferred Revenue, Noncurrent $9.75M.
- 2017-12-31: Deferred Revenue, Noncurrent $61.65M.
- 2017-09-30: Deferred Revenue, Noncurrent $144.33M.
- 2017-06-30: Deferred Revenue, Noncurrent $149.35M.
| Period end | Deferred Revenue, Noncurrent |
|---|---|
| 2018-03-31 | $9.75M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $61.65M 10-Q · filed 2018-05-08 |
| 2017-09-30 | $144.33M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $149.35M 10-Q · filed 2017-08-02 |
| 2017-03-31 | $154.36M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $159.37M 10-K · filed 2018-03-09 |
| 2016-09-30 | $164.39M 10-Q · filed 2016-11-01 |
| 2016-06-30 | $169.40M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $174.41M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $179.61M 10-K · filed 2017-03-09 |
| 2015-09-30 | $119.71M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $122.97M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $126.55M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $130.12M 10-K · filed 2016-03-10 |
| 2014-09-30 | $133.70M 10-Q · filed 2014-11-04 |
| 2014-06-30 | $137.28M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $142.86M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $148.87M 10-K · filed 2015-03-12 |
| 2013-09-30 | $8.53M 10-Q · filed 2013-11-13 |
| 2013-06-30 | $11.46M 10-Q · filed 2013-09-03 |
| 2012-12-31 | $17.32M 10-K · filed 2014-03-18 |